Shandong Buchang Pharmaceuticals Co., Ltd. (SHSE:603858) and Shandong Buchang Shenzhou Pharmaceutical Co., Ltd signed Cooperation Framework Agreement to acquire Beijing Chengrui Technology Co., Ltd. from Beijing Longle Zhixin Group Co., Ltd and Xu Shanshan for approximately CNY 270 million on October 16, 2021. As of October 10, 2021, The transaction received approval from the acquirer board. As of November 3, 2021, Beijing Chengrui obtained the business license issued by the Market Supervision Administration of Chaoyang District Beijing City recently.